Latest AstraZeneca News | Page 2

Calquence plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukaemia in the 1st-line setting
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for Breztri in patients with uncontrolled asthma published in…
NSW manufacturing can reduce gas consumption by 75% with the right policy support
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
Full Year and Q4 2025 results
The Cambridge x Manchester Innovation Partnership gathers pace following inaugural board meetings
Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus
Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
AusBiotech and Medicines Australia announce members of new joint advisory group to accelerate advanced therapies sector
AstraZeneca begins trading on the New York Stock Exchange
Imfinzi perioperative regimen recommended for approval in the EU by CHMP for patients with early gastric and gastroesophageal cancers
AstraZeneca enhances its weight management portfolio through collaboration agreement with CSPC Pharmaceuticals
AstraZeneca plans to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines
AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock Exchange
AstraZeneca appoints Joris Silon as Head of Investor Relations
Saphnelo self-administration TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in systemic lupus erythematosus disease activity
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
Cornell showcases a decade of impact through new community-engaged learning video series
Blood test offers hope for more effective ovarian cancer treatment
Finalists Announced For 2025 National Stroke Awards
ABC exposes Federal Government’s broken COVID-19 Vaccine Injury Claims Scheme
New research calls for lived experiences to improve cancer care and support
Global recognition for a pioneering marketing research leader
RFK Junior is stoking fears about vaccine safety. Here’s why he’s wrong – and the impact it could have
How pregnant women are tested for gestational diabetes is changing. Here’s what this means for you
Urban environments significantly increase risk of developing asthma – new research
Cancer patients from migrant backgrounds have a 1 in 3 chance of something going wrong in their care
First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune disease, NMOSD
How Beijing plans to bounce back against Trump’s tariffs
Protein In Nose Provides Information About COPD
5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
ITSN1 Gene Linked To Risk Of Parkinson’s Disease
AI accelerates discovery of neurodevelopmental disorder-associated genes
Ehrenberg-Bass has earned the undivided respect of global brands over 20 years
Elon Musk Talks ‘Tech Support’ Governance as World Leaders Champion Innovation-Driven Reforms at Dubai Summit
Cracking the code of lethal antibodies in a new blood-clotting disorder
Patients continue to be prioritised
New Year, New Medicines
New Research Reveals Two Types Of Fatty Liver Disease
First new treatment for asthma and COPD in half a century – new study
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
Enzyme engineering has the potential to drive green, more efficient drug manufacturing
One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics
What pathogen might spark the next pandemic? How scientists are preparing for ‘disease X’
An oral weight loss pill has just passed early trials with promising results – here’s how it works
Amcor Announces Changes To Board Of Directors
Businesses that try to come clean about their impact on nature can end up concealing more than they reveal